Literature DB >> 1532485

Differential effects of nifedipine on plasma atrial natriuretic peptide in normal subjects and hypertensive patients.

S Shigematsu1, T Yamada, T Aizawa, N Takasu, Z Shimizu.   

Abstract

The physiology of atrial natriuretic peptide (ANP) secretion was studied in normotensive subjects and hypertensive patients both young and old. Basal plasma ANP concentration was least in young normotensives, intermediate in old normotensives and young hypertensives, and highest in old hypertensives. Nifedipine, a known stimulator of ANP secretion, acutely increased plasma ANP in young and old normotensive subjects but not in young hypertensive patients and half of the old hypertensive patients. Increase in serum ANP level in response to nifedipine did not augment its hypotensive effect. However, the increase of aldosterone in response to nifedipine-induced rise in plasma renin activity (PRA) seemed to be suppressed by elevated ANP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532485     DOI: 10.1177/000331979204300105

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  2 in total

1.  Plasma atrial natriuretic peptide levels in essential hypertension after treatment with verapamil.

Authors:  B Kokkas; P Kotridis; M Karamouzis; I Kanonidis; G Sakadamis; G Dadous; S Haritos; P Kyriakoui; P C Papadopoulos; V Mirtsou-Fidani; C L Papadopoulos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jan-Mar       Impact factor: 2.441

Review 2.  Atrial natriuretic peptide contributes to the antihypertensive action of many drugs.

Authors:  C L Papadopoulos; B A Kokkas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Jan-Mar       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.